Exploring the Next Generation of Antibody–Drug Conjugates

0
91
Scientists highlight advances in each antibody–drug conjugate component — the monoclonal antibody, payload, linker and conjugation chemistry — and provide more-detailed discussions on selected examples of emerging novel antibody–drug conjugates of each format, enabled by engineering of one or more of these components.
[Nature Reviews Clinical Oncology]
Abstract